Skip to content

External Validation of the Updated International IgA Nephropathy Prediction Tool in a Chinese Population

External Validation of the Updated International IgA Nephropathy Prediction Tool in a Chinese Population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093550
Enrollment
Unknown
Registered
2024-12-06
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgA nephropathy

Interventions

IgAN patient group:None

Sponsors

The Second Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Renal pathology has a clear diagnosis of IgAN; Age >= 18 years at the time of biopsy; and has complete clinicopathological data

Exclusion criteria

Exclusion criteria: 1. The number of glomeruli is less than 8 at the time of renal biopsy 2. Lack of MEST-C score 3. Age less than 18 years old 4. Accompanied by other systemic diseases 5. Progression to ESRD at the time of biopsy and within 1 year after biopsy 6. Patients with less than 1 year of follow-up and lack of eGFR data around the baseline time point of 1 year after biopsy

Design outcomes

Primary

MeasureTime frame
50% decrease in glomerular filtration rate from baseline;End-stage renal disease;

Secondary

MeasureTime frame
Death; Lost to follow-up;

Countries

China

Contacts

Public ContactXuehong Lu

The Second Hospital of Jilin University

luxueh@jlu.edu.cn+86 155 2689 1216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026